Getinge AB
http://www.maquet.com/us/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Getinge AB
Getinge To Acquire Paragonix Technologies For About $477M
Getinge says it plans to pay about $477m for organ transport and services company Paragonix Technologies in an effort to “redefine the market standard in transplantation.”
MTI 100: Macro Challenges Make Demands Of Newly Resilient Medtechs
Global medtechs had a big enough challenge with COVID-19 and its aftermath before the full-scale regional conflict in Ukraine added more uncertainty to the question of when market normality would return.
Recalls For Datascope And Abiomed Designated Class I
The US FDA has updated a recall of Datascope Cardiosave IABPs to reflect its class I high-risk status and announced a recall of the labeling for Abiomed’s Impella RP Flex.
News We’re Watching: Disease X Act, Abiomed Recall, TAVR AI Cleared
This week, the bipartisan Disease X Act for pandemic preparedness was introduced in the US House of Representatives; Abiomed Impella pumps were the subject of a class I recall; Dasi Simulations and Endologix landed FDA clearances; and the FDA warned against the use of Getinge/Maquet Oxygenators.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Infection Control-Sterilization
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Atrium Medical Corp.
- Datascope Corporation
- Getinge Group
- Getinge GmBH
- InterVascular SAS
- InterVascular Inc.
- Maquet Getinge
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice